钛媒体:引领未来商业与生活新知 08月26日
特朗普重申降低药价承诺,威胁采取强硬措施
index_new5.html
../../../zaker_core/zaker_tpl_static/wap/tpl_guoji1.html

 

美国总统特朗普再次承诺大幅削减药品价格,此前他设定的药企降价最后期限临近。特朗普表示将削减1400%至1500%的药品价格,并强调将采取严厉措施应对药价过高问题。白宫此前已致函17家大型药企,要求其在9月29日前将美国处方药价格降至“最惠国”水平,否则将动用一切手段。此外,特朗普政府还加强了对药品进口的关税威胁,考虑对部分药品征收高达200%的关税,以鼓励药品在美国本土生产。

💊 特朗普政府正积极推动降低美国药品价格,总统特朗普近期重申了其大幅削减药价的承诺,并设定了最后期限。他声称将实现1400%至1500%的价格削减,显示出其在这一问题上的强硬立场。

📜 为实现降价目标,白宫已向17家主要西方制药公司发出信函,要求他们在9月29日前将美国处方药价格调整至“最惠国”待遇水平。信中警告,若药企不配合,政府将动用一切可用工具,以保护美国民众免受不合理的药品定价影响。

⚖️ 此外,特朗普政府还通过启动“230条款”调查,加强了对药品进口的关税威胁。此举被普遍视为可能对进口药品征收关税的前奏。特朗普曾表示,计划在一年或一年半的过渡期后,对进口药品征收高达200%的关税,以鼓励制药业回流美国本土生产。

TMTPOST --  U.S. President Donald Trump on Monday reiterated his pledge to substantially cut drug prices as the deadline he set for pharmaceutical companies to lower prices looms.


Credit:Freepik

Trump said he would slash drug prices by  1,400% to 1,500%. "Going to do a number on costs of drugs in US," he said during the briefing. The remarks reaffirmed his aggressive stance on pharmaceutical pricing and higher sectoral tariffs.

Trump two weeks ago has made one of his boldest claims in his promise to reduce drug prices. “You know, we’ve cut drug prices by 1,200, 1,300 and 1,400, 1,500%,” he told reporters on  August 10. He noted the reductions will start over the next two to three months. “I don’t mean 50%. I mean 14- 1,500%,” he said. 

The White House in late July said Trump had sent letters to 17 major pharmaceutical firms in the West outlining the steps they must take to lower the price of U.S. prescription drugs to “most favored nation” (MFN) levels by September 29.  

Companies to receive these letters include AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, EMD Serono, Roche’s subsidiary Genentech, Gilead, GSK, Johnson & Johnson, Merck, Novartis, Novo Nordisk, Pfizer, Regeneron and Sanofi. Trump in the letter warned if these companies “refuse to step up,” the U.S. government will deploy every tool in its “arsenal to protect American families from continued abusive drug pricing practices,” without specifying the possible measures.

The Trump administration has intensified the threat of tariffs on pharmaceutical imports since it in April opened a so-called Section 232 investigation into how importing certain pharmaceutical products affects national security. The move was widely seen as a prelude to initiating tariffs on drugs.

Trump during a Cabinet meeting on July 8 disclosed steep tariffs on the pharmaceutical sector will be announced “very soon”, while he could offer the pharmaceutical manufacturers at least a year for transition of their production to the U.S. before implementing the tariffs up to 200%.  

"We’re going to give people about a year, year and a half to come in, and after that they're going to be tariffed," Trump said in the meeting. "If they have to bring the pharmaceuticals into the country, … they're going to be tariffed at a very high rate — like 200%."

Trump a week later said he could impose impose tariffs on pharmaceuticals by August 1 and that levies on semiconductors could come soon as well. “Probably at the end of the month, and we’re going to start off with a low tariff and give the pharmaceutical companies a year or so to build, and then we’re going to make it a very high tariff,” Trump said on July 15. 

Trump earlier this month suggested he would impose even more hefty tariffs on pharmaceutical imports. "We'll be putting a initially small tariff on pharmaceuticals, but in one year — one and a half years, maximum — it's going to go to 150%. And then it’s going to go to 250%, because we want pharmaceuticals made in our country," Trump said in the CNBC interview on August 5.

更多精彩内容,关注钛媒体微信号(ID:taimeiti),或者下载钛媒体App

Fish AI Reader

Fish AI Reader

AI辅助创作,多种专业模板,深度分析,高质量内容生成。从观点提取到深度思考,FishAI为您提供全方位的创作支持。新版本引入自定义参数,让您的创作更加个性化和精准。

FishAI

FishAI

鱼阅,AI 时代的下一个智能信息助手,助你摆脱信息焦虑

联系邮箱 441953276@qq.com

相关标签

特朗普 药品价格 关税 美国政府 制药公司 Trump Drug Prices Tariffs US Government Pharmaceutical Companies
相关文章